LING YAN JIANG: Open Payments
NPI 1578991964 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,446 in 126 payments from 20 companies in 2025. Trend: 2023 $2,201 · 2024 $5,886 · 2025 $13,446
Travel & lodging: $9,325Food & beverage: $3,928Education: $193
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 5 | $9,630 |
| LEO Pharma Inc. | 28 | $570 |
| Galderma Laboratories, L.P. | 14 | $520 |
| Regeneron Healthcare Solutions, Inc. | 7 | $406 |
| Incyte Corporation | 11 | $321 |
| Janssen Biotech, Inc. | 12 | $308 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $297 |
| ABBVIE INC. | 5 | $209 |
| Novartis Pharmaceuticals Corporation | 7 | $196 |
| GENZYME CORPORATION | 6 | $188 |
Products named: DUPIXENT, NEMLUVIO, ADBRY, OPZELURA, TREMFYA, ILUMYA, ANZUPGO, RINVOQ.
Industry payments across NY — which companies pay providers there.
